Effect of carrier priming on immunogenicity of saccharide-protein conjugate vaccines
about
Factors contributing to the immunogenicity of meningococcal conjugate vaccinesEffects of alum adjuvant or a booster dose on immunogenicity during clinical trials of group B streptococcal type III conjugate vaccines.Linear and branched glyco-lipopeptide vaccines follow distinct cross-presentation pathways and generate different magnitudes of antitumor immunityReduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants.Structural properties of group B streptococcal type III polysaccharide conjugate vaccines that influence immunogenicity and efficacy.Carrier properties of a protein derived from outer membrane protein A of Klebsiella pneumoniae.Combined conjugate vaccines: enhanced immunogenicity with the N19 polyepitope as a carrier protein.On the power of chemical synthesis: immunological evaluation of models for multiantigenic carbohydrate-based cancer vaccines.Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine when administered to healthy Japanese adults aged ≥50 years. An open-label trial.Synthetic peptides representing T-cell epitopes act as carriers in pneumococcal polysaccharide conjugate vaccinesInfluence of preimmunization with tetanus toxoid on immune responses to tetanus toxin fragment C-guest antigen fusions in a Salmonella vaccine carrier.Mucosal immunogenicity of polysaccharides conjugated to a peptide or multiple-antigen peptide containing T- and B-cell epitopes.Characterization of a recombinant pneumolysin and its use as a protein carrier for pneumococcal type 18C conjugate vaccinesStructural and immunological characterization of Burkholderia pseudomallei O-polysaccharide-flagellin protein conjugatesMF59 adjuvant enhances antibody responses of infant baboons immunized with Haemophilus influenzae type b and Neisseria meningitidis group C oligosaccharide-CRM197 conjugate vaccine.Opposite effects of actively and passively acquired immunity to the carrier on responses of human infants to a Haemophilus influenzae type b conjugate vaccine.Immunogenicity of polysaccharides conjugated to peptides containing T- and B-cell epitopesAnalysis of immunological nonresponsiveness to the 19-kilodalton fragment of merozoite surface Protein 1 of Plasmodium yoelii: rescue by chemical conjugation to diphtheria toxoid (DT) and enhancement of immunogenicity by prior DT vaccination.A Rapid-Response Humoral Vaccine Platform Exploiting Pre-Existing Non-Cognate Populations of Anti-Vaccine or Anti-Viral CD4+ T Helper Cells to Confirm B Cell Activation.Serotype-specific and age-dependent generation of pneumococcal polysaccharide-specific memory B-cell and antibody responses to immunization with a pneumococcal conjugate vaccine.Potential carrier priming effect in Australian infants after 7-valent pneumococcal conjugate vaccine introductionSynthetic carbohydrate-based anticancer vaccines: the Memorial Sloan-Kettering experience.Identification of B- and T-cell epitopes of BB, a carrier protein derived from the G protein of Streptococcus strain G148.Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines.Immunodominance and functional activities of antibody responses to inactivated West Nile virus and recombinant subunit vaccines in mice.Non-epitope-specific suppression of the antibody response to Haemophilus influenzae type b conjugate vaccines by preimmunization with vaccine components.Effect of increased CRM₁₉₇ carrier protein dose on meningococcal C bactericidal antibody response.
P2860
Q28828544-D3DD9199-F713-41D3-9E92-1E01CE7724E8Q33552269-C91DF166-F190-46FB-A051-C5844C8F717DQ33614657-D26AD789-20CD-4824-8B0D-FC553C772237Q33753799-196C1E6C-1F79-49DF-8DF5-4B94DC6F1D8DQ33753897-C5A12F97-03A0-4DB5-BD90-93C3004882D7Q34002277-B8D75E5D-398F-40B0-A22B-37B5C2ECBE18Q34034071-DD89FFA5-A395-4C72-8838-5C657F9C89CDQ34160588-CA96A00F-A837-4C4B-AF97-A1628181AD3FQ34291076-DEB16A70-4868-4C6A-9F4D-0272C50AA340Q35393344-FF37E2F7-7259-4A0A-AD01-B45426839D52Q35422555-FB1A8632-AC6B-44E5-8303-EB6F116ADC53Q35423315-A12D6C09-5199-4397-8BD7-7AADC73D2DD4Q35424204-E9ED47C5-0C0A-42F4-9142-7F1704F203A1Q35507434-9CC5C603-066F-4A6A-9408-A6FA31F54280Q35546445-C8E36F8A-8564-4A68-91CE-62BF579DB8B4Q35770637-08278ECE-B204-4B74-A97D-9135735C419DQ35774613-A9786022-5579-41BF-B6C7-597BD22A4F5FQ36045018-3C4B4F60-0854-43A2-AE44-6EB9CEE36F56Q36197126-560F04BA-39F4-4533-A639-2D9CF8901F0EQ36452316-A17B476B-A867-4785-BE63-794E7E8CABBDQ37162391-DC9182F6-DBDA-43CF-8EE0-B9DFD730F1D0Q37608314-98081BAB-63D5-408F-AB04-F634925807A9Q39714037-FE509E6E-C658-4DEC-9742-2DFFDA1C49A3Q40056277-4CEB9301-7360-46DD-9796-C4C64680321AQ40340971-22065211-ABF3-4E20-B9CA-07A954A07741Q40373874-BE9C6CC3-F743-4671-8985-3366C7407F31Q41812746-CD5C4C49-4BF1-4701-8224-681767499279
P2860
Effect of carrier priming on immunogenicity of saccharide-protein conjugate vaccines
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Effect of carrier priming on immunogenicity of saccharide-protein conjugate vaccines
@en
type
label
Effect of carrier priming on immunogenicity of saccharide-protein conjugate vaccines
@en
prefLabel
Effect of carrier priming on immunogenicity of saccharide-protein conjugate vaccines
@en
P2093
P2860
P1476
Effect of carrier priming on immunogenicity of saccharide-protein conjugate vaccines
@en
P2093
Peeters CC
Poolman JT
Rijkers GT
Tenbergen-Meekes AM
P2860
P304
P407
P577
1991-10-01T00:00:00Z